Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (781-790 of 910) with videos related to

Pageof 91
Sort By:
Lancet (London, England)|January 26, 2002
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational studyMarjel J van Dam, Eric de Groot, Susanne M Clee, et al.
Human Molecular Genetics|September 25, 2012
A fully humanized transgenic mouse model of Huntington diseaseAmber L Southwell, Simon C Warby, Jeffrey B Carroll, et al.
The Pharmacogenomics Journal|April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, et al.
Nature Medicine|November 17, 2009
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtinShu-ichi Okamoto, Mahmoud A Pouladi, Maria Talantova, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
The Journal of Biological Chemistry|October 7, 2005
The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer diseaseVeronica Hirsch-Reinshagen, Luis F Maia, Braydon L Burgess, et al.
Atherosclerosis|December 4, 2003
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and functionJoanna M Karasinska, Franz Rinninger, Dieter Lütjohann, et al.
Journal of Lipid Research|May 6, 2003
Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1Cheryl L Wellington, Liam R Brunham, Steven Zhou, et al.
Human Gene Therapy|May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutationColin J D Ross, Jaap Twisk, Andrew C Bakker, et al.
Pageof 91

Showing results (781-790 of 910) with videos related to

Sort By:
Pageof 91
Lancet (London, England)|January 26, 2002
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational studyMarjel J van Dam, Eric de Groot, Susanne M Clee, et al.
Human Molecular Genetics|September 25, 2012
A fully humanized transgenic mouse model of Huntington diseaseAmber L Southwell, Simon C Warby, Jeffrey B Carroll, et al.
The Pharmacogenomics Journal|April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, et al.
Nature Medicine|November 17, 2009
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtinShu-ichi Okamoto, Mahmoud A Pouladi, Maria Talantova, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
The Journal of Biological Chemistry|October 7, 2005
The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer diseaseVeronica Hirsch-Reinshagen, Luis F Maia, Braydon L Burgess, et al.
Atherosclerosis|December 4, 2003
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and functionJoanna M Karasinska, Franz Rinninger, Dieter Lütjohann, et al.
Journal of Lipid Research|May 6, 2003
Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1Cheryl L Wellington, Liam R Brunham, Steven Zhou, et al.
Human Gene Therapy|May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutationColin J D Ross, Jaap Twisk, Andrew C Bakker, et al.
Pageof 91